Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
27.24
+0.65 (2.44%)
At close: Mar 9, 2026, 4:00 PM EDT
26.00
-1.24 (-4.55%)
After-hours: Mar 9, 2026, 7:58 PM EDT
Mineralys Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 2,156 | 613 | 354 | - | - | - |
| Market Cap Growth | 353.91% | 73.31% | - | - | - | - |
| Enterprise Value | 1,562 | 349 | 100 | - | - | - |
| Last Close Price | 27.24 | 12.31 | 8.60 | - | - | - |
| PB Ratio | 3.73 | 3.20 | 1.47 | - | - | - |
| P/TBV Ratio | 3.74 | 3.20 | 1.47 | - | - | - |
| Debt / Equity Ratio | - | - | - | - | - | -1.25 |
| Net Debt / Equity Ratio | -1.03 | -1.04 | -0.98 | -1.03 | -1.75 | -0.86 |
| Net Debt / EBITDA Ratio | 3.23 | 1.03 | - | - | - | - |
| Net Debt / FCF Ratio | 3.46 | 1.19 | 2.91 | 3.77 | 0.73 | -1.25 |
| Quick Ratio | 25.24 | 13.53 | 22.57 | 13.65 | 2.10 | 0.28 |
| Current Ratio | 25.50 | 14.02 | 23.77 | 13.98 | 2.20 | 0.29 |
| Return on Equity (ROE) | -42.14% | -82.24% | -41.38% | -53.00% | -1568.96% | - |
| Return on Assets (ROA) | -26.51% | -52.56% | -28.91% | -31.34% | -185.60% | - |
| Return on Capital Employed (ROCE) | -31.90% | -100.60% | -35.10% | -29.60% | -308.40% | 81.80% |
| Earnings Yield | -7.95% | -29.02% | -20.34% | - | - | - |
| FCF Yield | -7.95% | -27.16% | -22.96% | - | - | - |
| Buyback Yield / Dilution | -29.86% | -34.13% | -600.33% | -3.67% | -7.64% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.